Boston Scientific Corp.
(NYSE : BSX)

( )
BSX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
-1.70%97.220.6%$493.08m
ABTAbbott Laboratories
-1.54%82.940.8%$420.87m
ISRGIntuitive Surgical, Inc.
-1.31%513.722.4%$389.75m
TMOThermo Fisher Scientific Inc.
-0.44%292.231.0%$381.21m
BSXBoston Scientific Corporation
-0.79%41.391.1%$315.73m
BDXBecton, Dickinson and Company
-0.07%248.051.1%$314.30m
ALGNAlign Technology, Inc.
-2.88%268.086.3%$280.51m
EWEdwards Lifesciences Corporation
-2.55%187.061.2%$252.83m
SYKStryker Corporation
-0.70%202.371.3%$221.69m
DXCMDexCom, Inc.
-1.39%141.538.3%$195.92m
BAXBaxter International Inc.
-1.36%80.621.7%$185.36m
ABMDABIOMED, Inc.
-2.12%251.623.3%$147.60m
WATWaters Corporation
-0.09%211.083.8%$125.46m
ZBHZimmer Biomet Holdings, Inc.
-1.82%114.581.7%$122.92m
COOCooper Companies, Inc.
-0.49%328.372.2%$105.32m

Company Profile

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Cardiovascular, Rhythm Management, and MedSurg. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease, and other cardiovascular disorders including structural heart conditions. The Rhythm Management segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal, and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.